Sort
64,565 grants matching “drug discovery”
Discovery of Natural Product based Drugs and Bioenergetic Materials from CR
$954,100David H Sherman · University Of Michigan At Ann Arbor · U01 · FY2010 · TW
Therapeutic use of small-molecule HGF-mimetic for emphysema
$954,039Bert J. W. M. Oehlen · Angion Biomedica Corporation · R44 · FY2010 · HL
Project 1 UIC Targeting Protein Degradation ClpC1 ATPase
$953,949Scott G. Franzblau · Global Alliance For Tb Drug Development · U19 · FY2021 · AI
AdaptiSPECT-C: A Next-Generation, Adaptive Brain-Imaging SPECT System for Drug Discovery and Clinical Imaging
$953,794Michael A King · Univ Of Massachusetts Med Sch Worcester · R01 · FY2021 · EB
Discovery of new cellular targets for small-molecule inhibition of enveloped vir
$953,766Sean P. J. Whelan · Harvard Medical School · U19 · FY2018 · AI
Next-generation 5-nitroimidazoles against giardiasis
$953,513Lars Eckmann · University Of California, San Diego · U01 · FY2010 · AI
UT Southwestern Center for Translational Medicine (UL1/KL2/TL1
$953,416Robert Daniel Toto · Ut Southwestern Medical Center · KL2 · FY2015 · TR
Protein Structure, Stability, and Amyloid Formation
$953,343Ruth Nussinov · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Integrated, Individualized, Intelligent Prescribing (I3P)
$953,342Joshua C. Denny · Vanderbilt University · U01 · FY2015 · HG
Development of Oncomine Professional as a Platform for Biopharmaceutical Research
$953,247Daniel R Rhodes · Compendia Bioscience, Inc. · R44 · FY2009 · CA
GalNAc-specific measurement of Galactose-deficient IgA1 as a Biomarker for IgA nephropathy
$953,146Tomasz Szul · Reliant Glycosciences Llc · R44 · FY2025 · DK
DEVELOPMENTAL FUNDS (Core 002)
$953,077Norman Edward Sharpless · Univ Of North Carolina Chapel Hill · P30 · FY2016 · CA
Validation of Therapeutic Target and Underlying Biology
$953,058Gregory Scherrer · Univ Of North Carolina Chapel Hill · U19 · FY2024 · NS
Target and antibiotic discovery in Bacillus anthracis
$952,905Trius Therapeutics, Inc. · R44 · FY2004 · AI
Boron-containing antimalarial drug discovery
$952,800Steve Baker · Reactive Biosciences Inc · R44 · FY2023 · AI
AMP RA/SLE Leadership Center
$952,770Paul Joseph Utz · Stanford University · UM2 · FY2015 · AR
Parent Project - Main Theme (MAIN)
$952,700Mark J Ratain · University Of Chicago · U01 · FY2013 · GM
PDE4D PET Ligand
$952,592Mark E Gurney · Tetra Discovery Partners, Inc. · R44 · FY2018 · MH
Towards a quantitative understanding of tumor evolution
$952,560Raul Rabadan · Columbia University Health Sciences · R35 · FY2022 · CA
The Epilepsy Bioinformatics Study for Antiepileptogenic Therapy (EpiBioS4Rx) Project 2: Preclinical Model for Antiepileptogenic Therapy Screening in Post-traumatic Epilepsy
$952,506Aristea S Galanopoulou · University Of Southern California · U54 · FY2017 · NS
Glycosaminoglycan-Interacting Small Molecule (GISMO) as Alzheimer's Therapeutics
$952,480Paul Gregor · Gismo Therapeutics, Inc. · R44 · FY2018 · AG
ALZHEIMER AMYLOIDOGENESIS WITH NEW METHODS
$952,090Brigham And Women'S Hospital · P01 · FY2000 · AG
Assessing the effects of peripheral immune activation on the NVU following TBI using a vascularized and perfused human blood/BBB model
$952,000Dritan Agalliu · Columbia University Health Sciences · R61 · FY2021 · HL
In vivo Core
$951,755David R Andes · University Of Wisconsin-Madison · U19 · FY2021 · AI
Center for Genomics and Healthcare Equality
$951,630Wylie G Burke · University Of Washington · P50 · FY2014 · HG